Carlotti Didier N, Jacobs Dennis E
Cabinet de Dermatologie Vétérinaire, Heliopolis B3, av. de Magudas, F-33700 Bordeaux-Mérignac, France.
Department of Pathology and Infectious Diseases, The Royal Veterinary College (University of London), North Mymms, Hatfield, Herts AL9 7TA, United Kingdom.
Vet Dermatol. 2000 Jun;11(2):83-98. doi: 10.1046/j.1365-3164.2000.00204.x.
This article reviews contemporary concepts underlying the design of control strategies for the management of flea allergy dermatitis in dogs and cats. The limitations of palliative symptomatic approaches are noted, as is the fundamental requirement to differentiate simple pulicosis from true hypersensitivity. In the latter case, eradication of fleas from the affected animal and its surroundings has to be an essential aim. The different biological properties offered by modern chemotherapy are defined and the range of techniques for applying active compounds to the animal and its environment described. Factors for consideration when formulating control strategies and selecting chemotherapeutic agents are discussed in the context of the complexities of the flea life-cycle, the host-parasite relationship and client concerns.
本文综述了犬猫跳蚤过敏性皮炎管理控制策略设计背后的当代理念。文中指出了姑息性对症治疗方法的局限性，以及区分单纯跳蚤感染与真正过敏反应的基本要求。在后一种情况下，从受影响的动物及其周围环境中根除跳蚤必须是一个基本目标。文中定义了现代化学疗法所具有的不同生物学特性，并描述了将活性化合物应用于动物及其环境的一系列技术。在跳蚤生命周期的复杂性、宿主与寄生虫的关系以及客户关注点的背景下，讨论了制定控制策略和选择化学治疗剂时需要考虑的因素。
